These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 424857)

  • 1. [Effect of drug preparations used in treating coronary arteriosclerosis on the coagulogram and blood biochemical indices].
    Semavin IE; Goliakov VN; Semiletov VI; Solov'ev VV
    Sov Med; 1979 Jan; (1):31-5. PubMed ID: 424857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
    Kratovskaia OV; Zalaldinova NB; Afaunova VI; Denisova TP; Lebedeva SN
    Ter Arkh; 1972 Sep; 44(9):29-31. PubMed ID: 4660396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of hypotensive preparations on the blood coagulation and fibrinolysis indices in hypertension].
    Tsyrul'neva NI
    Vrach Delo; 1980 Oct; (10):32-5. PubMed ID: 7434699
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prolonged therapeutic-prophylactic use of anticoagulants].
    Kushelevskiĭ BP; Seliverstova GP
    Klin Med (Mosk); 1973 Apr; 51(4):26-8. PubMed ID: 4704262
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of the antioxidant, ionol, on blood coagulation in ischemic heart disease].
    Shkliar AS
    Vrach Delo; 1980 Sep; (9):52-4. PubMed ID: 7423951
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis].
    Markiewicz K; Cholewa M; Jazdzewski B; Gawor Z
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):857-61. PubMed ID: 6494044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of diets with a varying protein content on fibrinolysis in ischemic heart disease].
    Andreenko GV; Samsonov MA; Paramonova EG; Karabasova MA
    Vopr Pitan; 1978; (5):51-6. PubMed ID: 362708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation disorders and their correction in periodontal disease].
    Ivanov VS; Belikov PP
    Stomatologiia (Mosk); 1985; 64(6):44-7. PubMed ID: 3866401
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of anabolic steroid preparations on blood coagulation processes].
    Karacharov AT
    Klin Med (Mosk); 1971 Oct; 49(10):131-4. PubMed ID: 5133136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation and lipid metabolism in patients with coronary arteriosclerosis].
    Batrak AA
    Vrach Delo; 1976 Jun; (6):17-9. PubMed ID: 969450
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of linethol on the state of the blood coagulation and anticoagulation system in patients with coronary arteriosclerosis].
    Ezhova IS
    Ter Arkh; 1970 Aug; 42(8):49-51. PubMed ID: 5495039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of arachidene, a preparation of unsaturated fatty acids, on the blood coagulation and anticoagulation systems in patients with coronary arteriosclerosis].
    Ezhova IS
    Sov Med; 1971 Jul; 34(7):103-7. PubMed ID: 5160310
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation characteristics and fibrinolytic activity in patients with coronary arteriosclerosis during a course of treatment with vetrazine].
    Agapova EN; Krutovskaia OV; Mikhaĭlovskaia IG
    Kardiologiia; 1968 Dec; 8(12):130-2. PubMed ID: 5736735
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the indices of carbohydrate metabolism, of the lipoprotein spectrum and of the blood coagulation system in men with ischemic heart disease undergoing long-term propranolol treatment].
    Filatov NP; Ostrovskaia TP; Iliushina IP; Suvorova LA
    Ter Arkh; 1986; 58(1):60-5. PubMed ID: 3961694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nerobol on indices of the coagulogram in patients with rheumatism and circulatory insufficiency of the 2B-3 stage].
    Furtel' VA
    Vrach Delo; 1977 Jun; (6):38-9. PubMed ID: 302065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.